Dr. Marina Udier, COO of Nouscom, will give a talk about our company at the BaselArea.swiss Life Science Event on June 20, 2019 in Basel

The BaselArea.swiss Life Science event will have Dr. Marina Udier, COO of Nouscom, talking about the story of the company and sharing insights and learnings along the way.

Nouscom will present at the NeoAg Summit 2018

The 3rd NeoAg Summit is the leading end-to-end industry- focused meeting dedicated to advancing neoantigen-based cancer vaccines and cell therapies. Download the full program of NeoAg Summit 2018.

Nouscom will present at the World Vaccine Congress Europe 2018

Find out the full program here: https://www.terrapinn.com/conference/world-vaccine-congress-europe/agenda.stm  

Nouscom will present at Biocapital Europe

Find out the full program here: http://www.biocapitaleurope.com

NousCom presents at Agenda Sachs Forum

Full program: http://www.sachsforum.com/uploads/5/1/9/6/51964431/17thbef-finalagenda.pdf


Mainz, Germany Abstract Title: Great Apes Adenovirus neoantigens vaccine synergizes with immunomodulators in mouse models of cancer.

NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum

EMBL Heidelberg, Germany Full program: https://am.asco.org

NousCom presents at Agenda Sachs Forum

NousCom will present at the 17th Biotech In Europe Forum for Global Partnering and Investment. The forum wiil take place on 26th-27th September at the Congress Center Basel (switzerland). Feel [...]

NousCom presents at EMBL-Cancer Core Europe Conference: Cancer Immunotherapy

EMBL Heidelberg, Germany Abstract Title: Personalized cancer vaccine based on ChAd vaccine improves over the anti-PD1 activity.

NousCom presents at the 1ST Meeting of the European Hereditary Tumour Group (EHTG)

Palma, Mallorca Abstract Title: Development of cell based immunity based on multiple epitopes: Lessons from prophylactic genetic vaccines.